News related to Revlimid (Lenalidomide) and/or conditions it is approved for
Lenalidomide Now for Newly Diagnosed Multiple Myeloma Patients
Source: Medscape Hematology-Oncology Headlines [2015.02.25]
The FDA has expanded the indication for lenalidomide to include newly diagnosed multiple myeloma patients.
Medscape Medical News
Source: MedicineNet Aches, Pain, Fever Specialty [2015.02.26]
Title: Multiple Myeloma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/26/2015 12:00:00 AM
FDA approves Farydak for treatment of multiple myeloma
Source: Blood / Hematology News From Medical News Today [2015.02.25]
The U.S. Food and Drug Administration has approved Farydak (panobinostat) for the treatment of patients with multiple myeloma.
Farydak Approved for Multiple Myeloma
Source: MedicineNet Multiple Myeloma Specialty [2015.02.25]
Title: Farydak Approved for Multiple Myeloma
Category: Health News
Created: 2/24/2015 12:00:00 AM
Last Editorial Review: 2/25/2015 12:00:00 AM
FDA Approves Panobinostat for Relapsed Multiple Myeloma
Source: Medscape Hematology-Oncology Headlines [2015.02.23]
The first-in-class agent has been granted accelerated approval, despite having been voted down by the advisory committee late last year.
HDAC Inhibitor OK'd for Multiple Myeloma
Source: MedPage Today Oncology/Hematology [2015.02.23]
(MedPage Today) -- Panobinostat targets histone deacetylases; first of its kind to win approval in myeloma.